{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:50:05Z","timestamp":1775011805458,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/s0145-2126(02)00077-2","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T23:32:39Z","timestamp":1039563159000},"page":"79-84","source":"Crossref","is-referenced-by-count":30,"title":["The diphtheria toxin\/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells"],"prefix":"10.1016","volume":"27","author":[{"given":"Jason G","family":"Ramage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A","family":"Vallera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer H","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D","family":"Aplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula R","family":"Kees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur E","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(02)00077-2_BIB1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/blood.V98.3.548","article-title":"Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine","volume":"98","author":"Stone","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.V96.5.1670","article-title":"How I treat older patients with AML","volume":"96","author":"Estey","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0301-472X(00)00542-7","article-title":"Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells","volume":"28","author":"Feuring-Buske","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0145-2126(01)00034-0","article-title":"High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin\/IL-3 fusion protein","volume":"25","author":"Alexander","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-5793(94)00674-1","article-title":"Structure-function relationships in the receptor for urokinase-type plasminogen activator","volume":"349","author":"Ploug","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-6147(94)90130-9","article-title":"Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?","volume":"15","author":"Fazioli","year":"1994","journal-title":"Trends Pharmcol Sci"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0955-0674(00)00141-1","article-title":"Urokinase receptor: a molecular organizer in cellular communication","volume":"12","author":"Preissner","year":"2000","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1055\/s-0038-1650701","article-title":"Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells","volume":"76","author":"Jardi","year":"1996","journal-title":"Thrombosis Haemostasis"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.152.2.505","article-title":"Urokinase receptor: an activation antigen in human T lymphocytes","volume":"152","author":"Nykjaer","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2141.1998.00932.x","article-title":"Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells","volume":"103","author":"Lanza","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB11","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1074\/jbc.272.12.7824","article-title":"Molecular and functional characterization of the urokinase receptor on human mast cells","volume":"272","author":"Sillaber","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1055\/s-0038-1646019","article-title":"Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells","volume":"58","author":"Miles","year":"1987","journal-title":"Thrombosis Haemostasis"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajcp\/102.6.835","article-title":"Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue","volume":"102","author":"Plesner","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB14","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood.V96.8.2775","article-title":"Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix","volume":"96","author":"Kroon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB15","doi-asserted-by":"crossref","first-page":"21466","DOI":"10.1016\/S0021-9258(18)54662-7","article-title":"Urokinase binding and receptor identification in cultured endothelial cells","volume":"266","author":"Haddock","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB16","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1083\/jcb.103.6.2411","article-title":"The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type","volume":"103","author":"Plow","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcb.240320303","article-title":"The receptor for urokinase-plasminogen activator","volume":"32","author":"Blasi","year":"1986","journal-title":"J Cell Biochem"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB18","first-page":"1315","article-title":"Differential expression of a truncated form of the urokinase-type plasminogen activator receptor in normal and tumor thyroid cells","volume":"58","author":"Ragno","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0038-1656003","article-title":"The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage","volume":"77","author":"Wohn","year":"1997","journal-title":"Thrombosis Haemostasis"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/89.10.709","article-title":"Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines","volume":"89","author":"M\u2019Liss","year":"1997","journal-title":"JNCI"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB21","first-page":"4143","article-title":"Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody","volume":"53","author":"Mohanam","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB22","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1021\/bi010662g","article-title":"Peptide-derived antagonists of the urokinase receptor","volume":"40","author":"Ploug","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1096\/fj.14.10.1335","article-title":"Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism","volume":"14","author":"Ippoliti","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB24","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1074\/jbc.275.11.7566","article-title":"Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the a2-macroglobulin receptor","volume":"275","author":"Rajagopal","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/labinvest.3780354","article-title":"The urokinase plasminogen activator receptor-associated protein\/Endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis","volume":"81","author":"Engelholm","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB26","unstructured":"Vallera DA, Li C., Panoskaltsis-Mortari A, Hall WA, Targeting overexpressed urokinase-type plasminogen activator receptor (uPAR) on human glioblastoma with the diphtheria toxin fusion protein DTAT in nude mice, JNCI, (in press)."},{"key":"10.1016\/S0145-2126(02)00077-2_BIB27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5","article-title":"Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line","volume":"15","author":"Tanabe","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/(SICI)1098-2264(199607)16:3<204::AID-GCC8>3.0.CO;2-2","article-title":"ML-1 cell line lacks a germline MLL locus","volume":"16","author":"Strout","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/gcc.2870120307","article-title":"New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene in a childhood leukemia cell line","volume":"12","author":"Kees","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V85.3.855.bloodjournal853855","article-title":"Molecular analysis of the Mono Mac 6 cell line: detection of an MLL-AF9 fusion transcript","volume":"85","author":"Gill Super","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0145-2126(96)00129-4","article-title":"A model system in haematology and immunology: the human monocytic cell line MONO-MAC-1","volume":"21","author":"Steube","year":"1997","journal-title":"Leuk Res"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2000.02013.x","article-title":"Establishment and characterisation of an arsenic-sensitive monoblastic leukaemia cell line (SigM5)","volume":"109","author":"Walter","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z","article-title":"Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation","volume":"29","author":"Odero","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB34","first-page":"722","article-title":"Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines","volume":"13","author":"Potter","year":"1985","journal-title":"Exp Hematol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-4608(87)90138-5","article-title":"Transposition of breakpoint cluster region (3\u2019 bcr) in CML cells with variant Philiadelphia translocations","volume":"26","author":"Ohyashiki","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-4608(95)00214-6","article-title":"More detailed characterization of some of the HL60 karyotypic features by fluorescence in situ hybridization","volume":"87","author":"Volpi","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0753-3322(98)80013-9","article-title":"3-bromoacetylamino benzyolurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematology","volume":"52","author":"Jiang","year":"1998","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2402084","article-title":"Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice","volume":"15","author":"Kiser","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.133.1.123","article-title":"The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL-2 production reflects events occurring at a pre-translational level","volume":"133","author":"Weiss","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00393971","article-title":"Karyological characterization of a human lymphoblastoid cell line resistant to 6-thioguanine","volume":"35","author":"Yoshida","year":"1977","journal-title":"Hum Genet"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma","volume":"97","author":"Shou","year":"2000","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"10.1016\/S0145-2126(02)00077-2_BIB42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0955-0674(00)00109-5","article-title":"Penetration of protein toxins into cells","volume":"12","author":"Falnes","year":"2000","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1083\/jcb.141.3.815","article-title":"Mannose 6-phosphate\/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction","volume":"141","author":"Nykjaer","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB44","doi-asserted-by":"crossref","first-page":"23186","DOI":"10.1016\/S0021-9258(19)49445-3","article-title":"A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells","volume":"268","author":"Cavallaro","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1096\/fasebj.14.2.391","article-title":"Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells","volume":"14","author":"Fabbrini","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.leu.2400633","article-title":"Cytokine response profiles of human myeloid factor-dependent leukemia cell lines","volume":"11","author":"Drexler","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB47","first-page":"660","article-title":"Establishment and characterization of a human monocytoid leukemia cellline CTV-1","volume":"75","author":"Chen","year":"1984","journal-title":"Gann"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB48","first-page":"264","article-title":"Expression of a retinoid acid receptor gene in myeloid leukemia cells","volume":"3","author":"Wang","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V62.4.709.709","article-title":"Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications","volume":"62","author":"Koeffler","year":"1983","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V77.9.2031.2031","article-title":"Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation","volume":"77","author":"Asou","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(02)00077-2_BIB51","unstructured":"Minowada, J., Immunology of leukemic cells. In: Gunz, F, Henderson, E, editors. Leukemia. Orlando (FL, USA): Grune & Stratton, 1982. p. 119."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212602000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:59:41Z","timestamp":1682434781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212602000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0145212602000772"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(02)00077-2","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}